The Good, The Bad, and The Ugly in Medtech Deals

Some deals work and some deals don’t. A look at the good, bad and ugly deals in recent medtech history.

Omar Ford

February 23, 2024

9 Slides

There have been some truly exceptional deals that have shaped the medtech landscape. Some of these acquisitions have had a positive impact – and others … well, not so much.

MD+DI has rated the good, the bad, and the ugly of medtech deals.

And you can check out MD+DI’s annual Top Deals List here.

About the Author(s)

Omar Ford

Omar Ford

Omar Ford is MD+DI's Editor-in-Chief. You can reach him at [email protected].

 

See more from Omar Ford
Sign up for the QMED & MD+DI Daily newsletter.

You May Also Like

Editors' Choice

Recall
Regulatory & Quality
Elekta Disposable Biopsy Needle Recall Identified as Class I
Elekta Disposable Biopsy Needle Recall Identified as Class I

Apr 26, 2024

Q&A
Digital Health
Identifying the Privacy & Ethical Pitfalls in Connected Medical Devices
Identifying the Privacy & Ethical Pitfalls in Connected Medical Devices

Apr 26, 2024

M&A
A New Vision for Pixium’s Retinal Implants
Science Corporation to Acquire Pixium's Retinal Implants

Apr 26, 2024

Recent Headlines